Arca Biopharma sell StockNews.com
Start price
28.09.24
/
50%
€2.22
Target price
28.09.25
-
Performance (%)
-
End price
29.09.25
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Arca Biopharma | - | - | - |
| iShares Core DAX® | 1.644% | 4.865% | 25.089% |
| iShares Nasdaq 100 | 0.747% | 2.923% | 8.975% |
| iShares Nikkei 225® | 2.442% | 6.212% | 21.408% |
| iShares S&P 500 | 0.618% | 2.843% | 5.726% |
Comments by StockNews_com for this prediction
In the thread Arca Biopharma diskutieren
ARCA biopharma, Inc. (NASDAQ: ABIO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for ABIO provided by MarketBeat
In the thread Trading Arca Biopharma
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten